Your browser doesn't support javascript.
loading
The Singapore Asymptomatic Narrow Angles Laser Iridotomy Study: Five-Year Results of a Randomized Controlled Trial.
Baskaran, Mani; Kumar, Rajesh S; Friedman, David S; Lu, Qing-Shu; Wong, Hon-Tym; Chew, Paul T K; Lavanya, Raghavan; Narayanaswamy, Arun; Perera, Shamira A; Foster, Paul J; Aung, Tin.
Afiliación
  • Baskaran M; Department of Glaucoma, Singapore Eye Research Institute and Singapore National Eye Center, Singapore, Republic of Singapore; EYE-Academic Clinical Program, Duke-NUS Medical School, Singapore, Republic of Singapore; Department of Glaucoma, Medical and Vision Research foundation, Sankara Nethralaya,
  • Kumar RS; Department of Glaucoma, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, Cleveland Clinic Lerner College of Medicine, Case Western, Reserve University, Cleveland, Ohio.
  • Friedman DS; Glaucoma Center of Excellence, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.
  • Lu QS; EYE-Academic Clinical Program, Duke-NUS Medical School, Singapore, Republic of Singapore; Department of Biostatistics and Epidemiology, Singapore Clinical Research Institute, Singapore, Republic of Singapore.
  • Wong HT; Department of Glaucoma, Tan Tock Seng Hospital, Singapore, Republic of Singapore.
  • Chew PTK; Department of Glaucoma, National University Hospital and the Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore.
  • Lavanya R; Department of Glaucoma, Singapore Eye Research Institute and Singapore National Eye Center, Singapore, Republic of Singapore.
  • Narayanaswamy A; Department of Glaucoma, Singapore Eye Research Institute and Singapore National Eye Center, Singapore, Republic of Singapore.
  • Perera SA; Department of Glaucoma, Singapore Eye Research Institute and Singapore National Eye Center, Singapore, Republic of Singapore; EYE-Academic Clinical Program, Duke-NUS Medical School, Singapore, Republic of Singapore.
  • Foster PJ; National Biomedical Research Centre for Ophthalmology, UCL Institute of Ophthalmology and Moorfields Eye Hospital, London, United Kingdom.
  • Aung T; Department of Glaucoma, Singapore Eye Research Institute and Singapore National Eye Center, Singapore, Republic of Singapore; EYE-Academic Clinical Program, Duke-NUS Medical School, Singapore, Republic of Singapore; Department of Glaucoma, National University Hospital and the Yong Loo Lin School of
Ophthalmology ; 129(2): 147-158, 2022 02.
Article en En | MEDLINE | ID: mdl-34453952
PURPOSE: To examine the efficacy of laser peripheral iridotomy (LPI) in patients who received a diagnosis of primary angle-closure suspect (PACS). DESIGN: Prospective, randomized controlled trial. PARTICIPANTS: This multicenter, randomized controlled trial (ClinicalTrials.gov identifier, NCT00347178) enrolled 480 patients older than 50 years from glaucoma clinics in Singapore with bilateral asymptomatic PACS (defined as having ≥2 quadrants of appositional angle closure on gonioscopy). METHODS: Each participant underwent prophylactic LPI in 1 randomly selected eye, whereas the fellow eye served as a control. Patients were followed up yearly for 5 years. MAIN OUTCOME MEASURES: The primary outcome measure was development of primary angle closure (PAC; defined as presence of peripheral anterior synechiae, intraocular pressure [IOP] of >21 mmHg, or both or acute angle closure [AAC]) or primary angle-closure glaucoma (PACG) over 5 years. RESULTS: Of the 480 randomized participants, most were Chinese (92.7%) and were women (75.8%) with mean age of 62.8 ± 6.9 years. Eyes treated with LPI reached the end point less frequently after 5 years (n = 24 [5.0%]; incidence rate [IR], 11.65 per 1000 eye-years) compared with control eyes (n = 45 [9.4%]; IR, 21.84 per 1000 eye-years; P = 0.001). The adjusted hazard ratio (HR) for progression to PAC was 0.55 (95% confidence interval [CI], 0.37-0.83; P = 0.004) in LPI-treated eyes compared with control eyes. Older participants (per year; HR, 1.06; 95% CI, 1.03-1.10; P < 0.001) and eyes with higher baseline IOP (per millimeter of mercury; HR, 1.35; 95% CI, 1.22-1.50; P < 0.0001) were more likely to reach an end point. The number needed to treat to prevent an end point was 22 (95% CI, 12.8-57.5). CONCLUSIONS: In patients with bilateral asymptomatic PACS, eyes that underwent prophylactic LPI reached significantly fewer end points compared with control eyes over 5 years. However, the overall incidence of PAC or PACG was low.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glaucoma de Ángulo Cerrado / Iris / Iridectomía / Láseres de Estado Sólido Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Ophthalmology Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glaucoma de Ángulo Cerrado / Iris / Iridectomía / Láseres de Estado Sólido Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Ophthalmology Año: 2022 Tipo del documento: Article